Alitair
develops, manufactures and distributes drugs for the treatment of cough and bronchiectasis... Read moreAlitair
develops, manufactures and distributes drugs for the treatment of cough and bronchiectasis... Read more
Chairman & CEO
James E. Hoyes
News
Aug 03, 2018
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Dec 06, 2017
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Jan 05, 2017
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Nov 28, 2016
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc. Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
May 26, 2016
Business Wire
Press Release: Alitair : Global Bronchiectasis Pipeline Report 2016 - 12 Companies & Drug Profiles - Research and Markets
Jan 15, 2016
BioSpace
Alitair: Alitair Pharmaceuticals Announces Issuance Of Patent Covering Its Prescription Drug Overdose Reduction Technology, ODR
Jan 07, 2016
BioPortfolio
Alitair: Alitair Announces Issuance of Patent Covering Its Prescription Drug Overdose Reduction Technology ODR
Jan 06, 2016
Business Wire
Press Release: Alitair : Research and Markets: Bronchiectasis - Pipeline Review 2015
Oct 26, 2015
BIOPORTFOLIO
Alitair: Alitair Pharmaceuticals Inc. Selected to Present at October 2015 Cavendish Global Health Impact Forum
Oct 26, 2015
PRWEB
Press Release: Alitair : Alitair Pharmaceuticals, Inc. Selected to Present at October 2015 Cavendish Global Health Impact Forum
Alitair Competitors
1
2
3
4
5
6
7
8
9
10